Α dynamic growth of its financial results during the first six months of the current year 2006 has been achieved by IASO Group Of Companies.
At group level, revenues reached the amount of euro 71.245 mil. Vs. euro 57.154 mil of the same period in 2005, showing an increase of 24.7%, while earnings before interest taxes, depreciation and amortization (EBITDA) reached the amount of euro 15.065 mil. Vs. euro 8.923 mil of the same period in 2005, showing an increase of 68.8%.
The group's earnings before taxes amounted to euro 10.229 mil. Vs. euro 3.303 mil of the same period in 2005, representing an increase of 209.7%, while earnings after taxes and minority interests amounted to euro 7.274 mil. Vs. euro 2.633 mil. of the same period in 2005, increasing by 176.3%.
Regarding the parent Company's figures, revenues amounted to euro 43.480 mil. Vs. euro 37.280 mil. of the same period in 2005, increasing by of 16.6 %, while earnings before interest taxes, depreciation and amortization (EBITDA) reached euro 14.530 mil. Vs. euro 11.630 mil of the same period in 2005, showing an increase of 24.9%.
Earnings before taxes amounted to euro 12.924 mil. Vs. euro 9.496 mil. of the same period in 2005, increasing by 36.1%, while earnings after taxes and minority interests amounted to euro 9.144 mil. Vs. euro 6.063 mil of the same period in 2005, increasing by 50.8%.
The achievement of the above results is mainly attributed to:
- he revenues increase of the parent Company, as a result of the rise in the inpatients and outpatients inflow.
- The improvement of results of the subsidiary IASO General, which has already been established as one of the country's most well equipped general clinics, with medical and nursing personnel of high professional caliber. The supply of high level health services by Iaso General has been well perceived and recognized by the market; as a result thereof the company is experiencing a significant growth in admissions and in occupancy rate.
- The IASO Group's activation in the field of stem cells collection, processing and storage through its subsidiary MEDSTEM Services S.A. The Company operates the most highly scientifically and technologically equipped bank/unit of cord blood in Greece and the only private bank/unit that stores all the implants into its laboratories. It operates under the guidelines and control of one of the largest banks of America, Cryobanks International.